This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Nadine van Montfoort , Ph.D.
Assistant Professor and Group Leader at Leiden University Medical Centre


My primary research interest is immunity to tumors and viruses. My current research line on viro-immunotherapy of cancer integrates these two favourite topics. Oncolytic viruses (OV) are attractive anti-cancer therapeutics that selectively replicate and kill malignant cells while leaving normal cells unharmed. Beyond their tumor-killing properties, oncolytic viruses are emerging as immunotherapeutic tools to make resistant tumors more permissive for immunotherapy. Together with my group, I use pre-clinical models to study the immune-stimulatory mechanisms of oncolytic viruses. We focus on rational design of effective combination strategies of OV with other (immune)therapies, including bi-specific antibodies.

Agenda Sessions

  • Advances in T-Cell Engaging Therapies

  • Oncolytic Viruses As a Strategy to Sensitize Solid Tumors for Effective CD3-bispecific Antibody Therapy

    On Demand